NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

COLINZ LABORATORIES

BSE: 531210 21 Feb 2025
Healthcare
₹ 42.6
Colinz Laboratories ltd. specializes in Pharmaceuticals within the Healthcare sector.

COLINZ LABORATORIES - Share Price & Details

Market Cap
₹19.5
High /Low
84.4 / 36.0
Stock P/E
39.8
Book Value
₹20.5
Dividend Yield
0.0
ROCE
7.7
ROE
₹5.73
Face Value
10.0
PEG Ratio
1.22
EVEBITDA
₹14.3
Debt
0.81
CMP / FCF
31.6
Debt to equity
₹0.09
NP Ann
0.49
High price all time
84.4
Piotroski score
₹5.0
Graham Number
22.2
No. Eq. Shares
0.46
Net CF
₹1.27
Net profit
0.49
Price to book value
2.08
Interest Coverage
₹18.5
Low price all time
2.9
Industry PE
35.4
Reserves
₹6.83
Free Cash Flow
₹1.03

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
COLINZ LABORATORIES LTD.14.67NA39.8
Vanta Bioscience LimitedNANA
GENOMIC VALLEY BIOTECH LIMITED2.200.5146.6

Peer Comparison Chart


About COLINZ LABORATORIES

Colinz Laboratories ltd., with Security Code 531210, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Colinz Laboratories Receives 'Hold' Rating After Positive Results and Strong Cash Flow

(10 Dec 2024)
Colinz Laboratories, a microcap pharmaceutical company, has recently received a 'Hold' rating from MarketsMOJO. This upgrade comes after the company...
Read more →

Colinz Laboratories standalone net profit rises 33.33% in the September 2024 quarter

(31 Oct 2024)
Net profit of Colinz Laboratories rose 33.33% to Rs 0.16 crore in the quarter ended September 2024 as against Rs 0.12 crore during the previous quarter...
Read more →

Colinz Labs Standalone September 2024 Net Sales at Rs 1.86 crore, up 4.31% Y-o-Y

(31 Oct 2024)
Net Sales at Rs 1.86 crore in September 2024 up 4.31% from Rs. 1.79 crore in September 2023. Story continues below Advertisement.
Read more →

Shares below Rs 100: Only buyers were seen in these stocks on October 31

(31 Oct 2024)
As of October 31, 2024, the market capitalisation of BSE-listed companies was approximately Rs 4.44 lakh crore or USD 5.28 trillion.
Read more →

Q2 results today: L&T, Tata Power, P&G, Dabur among 77 to post earnings

(30 Oct 2024)
Q2FY25 Company results Today, October 30: Aditya Birla Capital, Protean eGov Technologies, TTK Prestige, and New India Assurance will...
Read more →

Over 50 companies to post Q2FY25 results; L&T, Tata Power, KRN Heat Exchanger on the list

(30 Oct 2024)
3IINFOLTD, 3I INFOTECH LTD. AASHKA, Aashka Hospitals Ltd. ABCAPITAL, Aditya Birla Capital Ltd. AEROFLEX, Aeroflex Industries Ltd.
Read more →